Searched for
LUPIN FACILITY
Stocks in news: Hero MotoCorp, Canara Bank, Bharti Airtel, Indian Hotels, SBIIndian markets opened positively, with analysts suggesting a stock-specific strategy amidst consolidation. Hero MotoCorp sees a revival in ...- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- Beyond rice, wheat: Why India must revive native ‘orphan crops’ for protein securityIndia can boost nutrition security, cut import dependence, and build a global smart protein industry by scaling climate-resilient indigenou...
- Pharma Q4 outlook mixed: Hospitals steady, generics face revlimid dragIndian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lo...
- Stocks in news: HDFC Bank, ICICI Bank, RIL, Trent, Jio FinancialIndian markets are set for a dynamic start today. Investors will closely watch the Q4 results from banking giants HDFC Bank and ICICI Bank....
- Lupin to set up new facility in US with an investment of USD 250 mnDrug firm Lupin will establish a new manufacturing plant in Coral Springs, Florida. The investment totals USD 250 million over five years. ...
- Lupin gets EIR for Pithampur Unit-2, paves way for resolving warning letterThe EIR represents the closure of the inspection, and also paves the way for possible lifting of warning letters on the facility imposed by...
- Lupin gets warning letter from USFDA for Somerset facilityThe United States Food and Drug Administration (USFDA) had inspected the company's Somerset, New Jersey, facility from September 10, 2020, ...
- Irish drug regulator clears Lupin Pune unit after virtual inspectionLupin’s Pune facility is known for its R&D and manufacturing work related to biosimilars.
- Lupin gets 2 observations from USFDA for Nagpur facility"The inspection closed with two 483 observations," Lupin said.
- Lupin gets EIR from USFDA for Nagpur facilityUSFDA conducted the inspection between August 5-8, 2019, Lupin said in a filing to the BSE.
- Lupin gets 3 observations from USFDA for its Tarapur facilityThe inspection of Tarapur facility was carried out by the United States Food and Drug administration (USFDA) between September 16-20, 2019.
- Sell Lupin, target Rs 800: Elara CapitalSell Lupin at a price target of Rs 800.
- Lupin Pharma gets Good Manufacturing Certificate for its biologic plantBiosimilar Etanercept is used to fight a range of severe auto-immune disorders.
- Lupin gets EIR from USFDA for Pithampur facility unitLupin's Pithampur facility manufactures dermatological products, dry product inhalers, and metered dose inhalers.
- USFDA makes 22 observations post inspection of Lupin's Mandideep facilitiesLupin said the observations are "largely procedural in nature with some gaps identified in the aseptic processing areas of the Cephalospori...
- Lupin gets EIR from USFDA for Nagpur facilityCommenting on the development, Lupin MD Nilesh Gupta said, "The successful completion of the Nagpur facility inspection is a positive devel...
- Lupin gets EDQM nod for its Mandideep facilityThe inspection was focused on the application for certificate of suitability for the dossier of Cefaclor along with facility inspection for...
- USFDA completes inspection of Lupin's Nagpur plantNo observations were made following the inspection of the facility that manufactures oral solid products in the coastal state of Maharashtr...
- Lupin pharma gets USFDA nod to market ophthalmic solutionThe company said it has received the final approval for its product, a generic version of Allergan Inc's Lumigan Ophthalmic Solution, from ...
Load More
